Degenerative Disc Disease News and Research

RSS

RIT researchers use CRISPR to develop new treatment for degenerative disc disease

Rochester Institute of Technology researchers are improving non-invasive treatment options for degenerative disc disease, an ailment that impacts 3 million adults yearly in the U.S., according to the Mayo Clinic.

6 Sep 2023

Artificial intelligence may influence whether you can get pain medication

Elizabeth Amirault had never heard of a Narx Score. But she said she learned last year the tool had been used to track her medication use.

30 Aug 2023

New clinical trial seeks a regenerative pharmaceutical solution for meniscal tears

With support from Amplicore, a University of Cincinnati spinoff biopharmaceutical company, researchers at UC have begun a Department of Defense-funded clinical trial that seeks a regenerative pharmaceutical solution for meniscal tears.

10 Jul 2023

Newly developed hydrogel proven effective in relieving chronic low back pain

An experimental formulation of a hydrogel, injected into spinal discs, proved safe and effective in substantially relieving chronic low back pain caused by degenerative disc disease (DDD), according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting, in Boston.

8 Jun 2022

Novel robotic replica of human spine enables surgeons to preview the effects of surgery

Degenerative disc disease affects about 40 percent of people aged 40, increasing to about 80 percent among those aged 80 or older. The disease, which is the deterioration of one or more intervertebral discs of the spine, often is surgically treated with cervical disc implants.

19 Jan 2022

Milestone study uncovers genetic risk factors for spine osteoarthritis

Scientists from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed), contributing as part of the 'Genetics of Osteoarthritis (GO)' consortium to the world's largest study of over 800,000 individuals, have identified genetic risk factors - variants associated with SOX5 and CHST3 genes, key regulators of the development of the intervertebral discs, to be implicated in spine osteoarthritis (OA).

8 Nov 2021

New two-step technique to repair herniated discs

A new two-step technique to repair herniated discs uses hyaluronic acid gel to re-inflate the disc and collagen gel to seal the hole, essentially repairing ruptured discs like you'd repair a flat tire.

11 Mar 2020

AAOMPT opposes use of 'degenerative disc disease' as diagnostic term for neck, back pain

The American Academy of Orthopaedic Manual Physical Therapists has released a position statement opposing "degenerative disc disease" as a diagnostic term for the cause of neck and back pain.

25 Oct 2019

DePuy Synthes introduces 3D-printed titanium interbody implants for spinal fusion surgery

The Johnson & Johnson Medical Devices Companies today announced that DePuy Synthes has launched the CONDUIT Interbody Platform with EIT Cellular Titanium Technology, further expanding its comprehensive offering to treat degenerative spine disease.

From DePuy Synthes 26 Sep 2019

New robotic technology increases the safety and precision of spinal fusion surgeries

A new technology that increases the safety and precision of spinal fusion surgeries while reducing the time needed for the procedure now is available at Rush University Medical Center.

3 Jun 2019

Renishaw partnership demonstrates AM capabilities for spinal implants

Global engineering company Renishaw has collaborated with two advanced technology companies to demonstrate the advantages of additive manufacturing in the production of spinal implants.

From Renishaw plc - Spectroscopy 5 Mar 2019

Medtronic announces U.S. launch of Infinity OCT System

Medtronic plc today announced the U.S. launch of the Infinity Occipitocervical-Upper Thoracic System designed to simplify posterior cervical spine surgery.

From Medtronic 27 Sep 2018

RTI Surgical showcases innovative spine portfolio at NASS 2018

RTI Surgical, Inc., a global surgical implant company, will showcase research reinforcing the strength of its spine portfolio, notably the Fortilink IBF series featuring TETRAfuse 3D Technology, at the North American Spine Society's 33rd Annual Meeting in Los Angeles, September 26-29.

26 Sep 2018

Mesoblast’s MPC therapy for children featured at symposium for congenital heart disease

Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.

26 Sep 2018

RTI's TETRAfuse 3D Technology wins 2018 Spine Technology Award

RTI Surgical, Inc., a global surgical implant company, announced its TETRAfuse 3D Technology won a 2018 Spine Technology Award from Orthopedics This Week, a widely read publication in the orthopedics industry.

25 Sep 2018

DePuy Synthes introduces CONCORDE LIFT Expandable Interbody Device at EUROSPINE 2018

DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies today unveiled the CONCORDE LIFT Expandable Interbody Device to European Surgeons at the EUROSPINE 2018 Meeting, taking place in Barcelona, Spain.

From DePuy Synthes 20 Sep 2018

Johnson & Johnson Medical acquires EIT to enhance interbody implant portfolio

Johnson & Johnson Medical Devices Companies, through its subsidiary Johnson & Johnson Medical GmbH, announced today the acquisition of Emerging Implant Technologies GmbH, a privately held manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery, based in Wurmlingen, Germany.

From Johnson & Johnson 14 Sep 2018